New drug duo tested for Tough-to-Treat bone cancer
NCT ID NCT07479732
Summary
This study is testing a combination of two drugs, apatinib and liposomal irinotecan, for people with advanced osteosarcoma (a type of bone cancer) that has come back or spread after standard chemotherapy. The main goals are to find the safest and most effective dose of the two drugs together and to see how well they work at controlling the cancer. It is for patients whose cancer has progressed after at least two prior lines of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.